Read More Pharma Industry News Urovant Sciences acquires licensing for hMaxi-K gene therapy to treat overactive bladder from Ion Channel Urovant Sciences has secured global licensing rights from Ion Channel Innovations for the development and commercialization of a… bypharmanewsdailyAugust 29, 2018